跳至主要内容
临床试验/NCT03634852
NCT03634852已完成4 期

A Two Different Chemoprophylaxis Approaches After Phacoemulsification Surgery in One Thousand Patients in Iraq :a Clinical Trial

Suzan A Rattan0 个研究点目标入组 1,000 人开始时间: 2016年10月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
1,000
主要终点
Incidence of Bacterial endophthalmitis in 1000 phacoemulsification surgeries

研究概览

简要总结

Post cataract surgery bacterial endophthalmitis is a rare but the most devastating complication with a poor visual outcome.

The preferred pattern of chemoprophylaxis varied world widely. The use of preoperative povidone iodine is universal. Most European surgeons prefer the use of Intracameral (IC) antibiotics whereas topical fluoroquinolone that prescribed perioperatively is the most common pattern in the United state(US). The current study aimed to evaluate the effectivity and safety of a combination of diluted IC Moxifloxacin and subconjunctival (SC) Triamcinolone acetonide as prophylaxis of bacterial endophthalmitis and postoperative inflammation in five hundred phacoemulsification surgeries and compare its results with the same number of patients treated by topical Moxifloxacin hydrochloride and Dexamethasone eye drops when given four times a day for 1month postoperatively.

详细描述

Study design and populations:

The current clinical trial included a total 1000 patients with visually significant cataract scheduled to have phacoemulsification surgery at an Eye specialty private hospital in Baghdad /Iraq during 18 months period from 1st of October 2016 to 1st of February 2018 by two surgeons.

The current two methods of prophylaxis of postoperative endophthalmitis and inflammation were discussed with the patients and informed consent was obtained about the treatment and the enrollment in the current study.

Two methods of prophylaxis of postoperative bacterial endophthalmitis and inflammation were planned to use. For 500 patients (group 1) topical moxifloxacin hydrochloride 0.5% (Vigamox,Alcon) and dexamethasone 0.1%(Maxidex, Alcon) eye drops prescribed four times a day for 1-month postoperatively ,while for the remaining 500 patients (group 2), intracameral (IC) diluted moxifloxacin 0.1% and subconjunctival triamcinolone acetonide 4 mg/0.4 cc is the combination that planned to used for prophylaxis.

Preoperative evaluations:

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
38 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • for both groups; the patients with visually significant cataract were included in the current study should have
  • no current or previous intraocular inflammation,
  • no history of glaucoma or topical corticosteroid responsiveness.
  • All the included patients had normal preoperative fundus examination and normal preoperative macular OCT.
  • All the patients who have the above-mentioned inclusion criteria were included in the current comparison whether phacoemulsification surgery was complicated or not.

排除标准

  • For group 2; any patient used a topical antibiotic, nonsteroidal anti-inflammatory drug (NSAID) or corticosteroid up to 1 week before the planned day of surgery,
  • any patient with a history of glaucoma or steroid responsiveness
  • any patient with significant maculopathy were excluded from the current comparison.

研究组 & 干预措施

Topical

Active Comparator

Moxifloxacin hydrochloride 0.5% eye drops and dexamethasone 0.1% eye drops were prescribed four times a day for 1 month postoperatively.

干预措施: Moxifloxacin hydrochloride 0.5% eye drops (Drug)

Topical

Active Comparator

Moxifloxacin hydrochloride 0.5% eye drops and dexamethasone 0.1% eye drops were prescribed four times a day for 1 month postoperatively.

干预措施: Dexamethasone 0.1% eye drops (Drug)

Intracameral - Subconjunctival

Active Comparator

Intracameral Moxifloxacin 0.1% with Subconjunctival Triamcinolone acetonide 4 mg /0.4 ml had been administered at the conclusion of the surgery

干预措施: Intracameral Moxifloxacin 0.1% (Drug)

Intracameral - Subconjunctival

Active Comparator

Intracameral Moxifloxacin 0.1% with Subconjunctival Triamcinolone acetonide 4 mg /0.4 ml had been administered at the conclusion of the surgery

干预措施: Subconjunctival Triamcinolone acetonide 4 mg /0.4 ml (Drug)

结局指标

主要结局

Incidence of Bacterial endophthalmitis in 1000 phacoemulsification surgeries

时间窗: The duration of follow up for each patient was a 3 months postoperatively.

All patients assessed by slit lamp examination for possibility of early or late onset bacterial endophthalmitis after phacoemulsification surgery.

次要结局

  • Intraocular pressure(IOP) was measured on 1week,1month,and 3 months visits by Goldmann applanation tonometry .(The duration of follow up for each patient was a 3 months postoperatively.)

研究者

发起方
Suzan A Rattan
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Suzan A Rattan

Assistant professor in ophthalmology

Al-Kindy College of Medicine

相似试验